Universal or “pan-cancer” testing panels are broad and comprehensive; any patent meeting the criteria for breast cancer or colon cancer panel likely qualifies, yet patients are not doing so. They are vastly under-utilized. DocWire News spoke with Dr. Sadie Debrozsi, of Evolent, about ways we can change this problem, including being unified as a scientific community and working toward unifying policies. ...
Oncology
Advertisement
Dr. John Fruehauf provided an in-depth overview of treatments for metastatic melanoma.
The primary outcomes of the study were melanoma-related deaths and nonmelanoma-related deaths.
The CDK4/6 inhibitor showed meaningful improvement in HR+, HER+ disease.
The researchers hypothesized that the prognostic value of diurnal cortisol aberrations will hold in HNC.
The positive predictive value for cancer was 15% higher for those enrolled.
TPC2 and Rab7a interaction may be responsible for melanoma proliferation.
The most frequent changes detected were additional copies of chromosome 1q and losses of chromosomes 10q, 16q, and 22.
Based on these results, a three-diode laser vaginal session enhances and favors the complete closure of VVFs.
Remote analysis of cancerous-looking skin growths yields the same level of accuracy as in-person analysis.
Twelve chemicals were associated with increased breast cancer risk.
Advertisement
Expert Interviews on Oncology
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.